Literature DB >> 18790088

Effect of Lactobacillus acidophilus strain L-55 on the development of atopic dermatitis-like skin lesions in NC/Nga mice.

Yosuke Sunada1, Syoji Nakamura, Chiaki Kamei.   

Abstract

In this study, we examined whether Lactobacillus acidophilus strain L-55 (strain L-55) suppresses the development of atopic dermatitis (AD)-like skin lesions induced by repeated application of 2,4,6-trinitrochlorobenzene (TNCB) in sensitized NC/Nga mice. The effect of strain L-55 was assessed by measuring clinical symptoms, ear swelling, scratching behavior and serum levels of total IgE. Strain L-55 was administered orally once a day: Strain L-55 at doses of 1 and 10 mg cells/mouse inhibited the development of AD-like skin lesions in dermatitis scores for the back. The increase of dermatitis score and ear swelling was also inhibited by strain L-55. In addition, strain L-55 also caused an inhibition of histological changes induced by repeated application of TNCB. Scratching behavior observed in the back and ear was inhibited by strain L-55. Furthermore elevated serum IgE levels observed by TNCB were also decreased by strain L-55. These results indicate that the inhibition of strain L-55 on AD-like lesions induced by repeated application of TNCB in sensitized NC/Nga mice occurred via a decrease in the serum total IgE level.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18790088     DOI: 10.1016/j.intimp.2008.08.011

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  7 in total

Review 1.  A review of the advancements in probiotic delivery: Conventional vs. non-conventional formulations for intestinal flora supplementation.

Authors:  Mershen Govender; Yahya E Choonara; Pradeep Kumar; Lisa C du Toit; Sandy van Vuuren; Viness Pillay
Journal:  AAPS PharmSciTech       Date:  2013-09-25       Impact factor: 3.246

2.  Potential for tyndalized Lactobacillus acidophilus as an effective component in moisturizing skin and anti-wrinkle products.

Authors:  A-Rang Im; Hui Seong Kim; Jin Won Hyun; Sungwook Chae
Journal:  Exp Ther Med       Date:  2016-05-31       Impact factor: 2.447

3.  Extract from peel of Citrus natsudaidai alleviates experimental chronic allergic dermatitis in mice.

Authors:  Noriyuki Nakayama; Katsunori Yamaura; Maki Shimada; Koichi Ueno
Journal:  Pharmacognosy Res       Date:  2011-07

Review 4.  Preventative and therapeutic probiotic use in allergic skin conditions: experimental and clinical findings.

Authors:  Öner Özdemir; Azize Yasemin Göksu Erol
Journal:  Biomed Res Int       Date:  2013-09-01       Impact factor: 3.411

5.  Draft Genome Sequence of Probiotic Lactobacillus acidophilus Strain L-55 Isolated from a Healthy Human Gut.

Authors:  Yusuke Fujii; Hidehiro Toh; Takehiro Matsubara; Shuta Tomida; Co Thi Kim Nguyen; Iyo Mimura; Shoji Nakamura; Hidetoshi Morita
Journal:  Genome Announc       Date:  2016-12-08

6.  Therapeutic effects of orally administered CJLP55 for atopic dermatitis via the regulation of immune response.

Authors:  Kyeong Eun Hyung; Soo Jeong Kim; Ye Won Jang; Da Kyoung Lee; Kee Hyeob Hyun; Byoung Seok Moon; Bongjoon Kim; Heeyoon Ahn; So-Young Park; Uy Dong Sohn; Eon Sub Park; Kwang Woo Hwang
Journal:  Korean J Physiol Pharmacol       Date:  2017-04-21       Impact factor: 2.016

7.  Lactobacillus paracasei KBL382 administration attenuates atopic dermatitis by modulating immune response and gut microbiota.

Authors:  Woon-Ki Kim; You Jin Jang; Dae Hee Han; Kyungchan Jeon; Cheonghoon Lee; Hyuk Seung Han; GwangPyo Ko
Journal:  Gut Microbes       Date:  2020-11-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.